Charles Schwab Investment Management Inc Exelixis, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 3,236,075 shares of EXEL stock, worth $117 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,236,075
Previous 3,321,407 2.57%
Holding current value
$117 Million
Previous $123 Million 16.33%
% of portfolio
0.03%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$34.13 - $46.26 $2.91 Million - $3.95 Million
-85,332 Reduced 2.57%
3,236,075 $143 Million
Q1 2025

Sep 15, 2025
BUY
$32.38 - $39.16 $2.76 Million - $3.34 Million
85,332 Added 2.64%
3,321,407 $123 Million
Q1 2025

May 09, 2025
BUY
$32.38 - $39.16 $2.24 Million - $2.7 Million
69,054 Added 2.12%
3,321,407 $123 Million
Q4 2024

Feb 06, 2025
SELL
$25.39 - $36.46 $539,969 - $775,394
-21,267 Reduced 0.65%
3,252,353 $108 Million
Q3 2024

Nov 12, 2024
SELL
$21.96 - $27.6 $726,239 - $912,759
-33,071 Reduced 1.0%
3,273,620 $85 Million
Q2 2024

Aug 12, 2024
SELL
$20.34 - $23.73 $1.26 Million - $1.47 Million
-61,934 Reduced 1.84%
3,306,691 $74.3 Million
Q1 2024

May 08, 2024
BUY
$20.17 - $23.93 $83,604 - $99,189
4,145 Added 0.12%
3,368,625 $79.9 Million
Q4 2023

Feb 06, 2024
BUY
$19.25 - $24.13 $555,170 - $695,909
28,840 Added 0.86%
3,364,480 $80.7 Million
Q3 2023

Nov 08, 2023
BUY
$19.04 - $22.74 $1.11 Million - $1.33 Million
58,320 Added 1.78%
3,335,640 $72.9 Million
Q2 2023

Aug 09, 2023
BUY
$18.17 - $20.48 $717,188 - $808,366
39,471 Added 1.22%
3,277,320 $62.6 Million
Q1 2023

May 11, 2023
SELL
$16.3 - $19.41 $2.33 Million - $2.77 Million
-142,853 Reduced 4.23%
3,237,849 $62.8 Million
Q4 2022

Feb 13, 2023
BUY
$14.96 - $17.39 $1.77 Million - $2.06 Million
118,600 Added 3.64%
3,380,702 $54.2 Million
Q3 2022

Nov 14, 2022
BUY
$15.68 - $22.27 $3.27 Million - $4.64 Million
208,309 Added 6.82%
3,262,102 $51.2 Million
Q2 2022

Aug 15, 2022
BUY
$17.44 - $23.16 $1.76 Million - $2.34 Million
101,090 Added 3.42%
3,053,793 $63.6 Million
Q1 2022

May 13, 2022
BUY
$17.03 - $22.67 $4.15 Million - $5.52 Million
243,453 Added 8.99%
2,952,703 $66.9 Million
Q4 2021

Feb 11, 2022
BUY
$15.84 - $21.88 $2.38 Million - $3.29 Million
150,490 Added 5.88%
2,709,250 $49.5 Million
Q3 2021

Nov 16, 2021
BUY
$16.3 - $21.14 $14.3 Million - $18.5 Million
877,233 Added 52.17%
2,558,760 $54.1 Million
Q2 2021

Aug 16, 2021
BUY
$17.95 - $25.56 $1.71 Million - $2.44 Million
95,518 Added 6.02%
1,681,527 $30.6 Million
Q1 2021

May 17, 2021
BUY
$20.53 - $25.22 $1.03 Million - $1.27 Million
50,237 Added 3.27%
1,586,009 $35.8 Million
Q4 2020

Feb 16, 2021
BUY
$18.39 - $24.8 $396,653 - $534,911
21,569 Added 1.42%
1,535,772 $30.8 Million
Q3 2020

Nov 13, 2020
BUY
$20.67 - $26.94 $529,565 - $690,202
25,620 Added 1.72%
1,514,203 $37 Million
Q2 2020

Aug 14, 2020
BUY
$16.46 - $27.42 $636,179 - $1.06 Million
38,650 Added 2.67%
1,488,583 $35.3 Million
Q1 2020

May 15, 2020
BUY
$14.46 - $21.8 $438,875 - $661,651
30,351 Added 2.14%
1,449,933 $25 Million
Q4 2019

Feb 07, 2020
SELL
$15.15 - $18.89 $218,326 - $272,223
-14,411 Reduced 1.0%
1,419,582 $25 Million
Q3 2019

Nov 08, 2019
BUY
$17.68 - $22.65 $1.79 Million - $2.29 Million
101,286 Added 7.6%
1,433,993 $25.4 Million
Q2 2019

Aug 09, 2019
BUY
$18.93 - $24.75 $1.09 Million - $1.42 Million
57,570 Added 4.51%
1,332,707 $28.5 Million
Q1 2019

May 14, 2019
BUY
$19.6 - $24.76 $1.8 Million - $2.27 Million
91,756 Added 7.75%
1,275,137 $30.3 Million
Q4 2018

Feb 14, 2019
BUY
$13.65 - $21.8 $538,779 - $860,467
39,471 Added 3.45%
1,183,381 $23.3 Million
Q3 2018

Nov 13, 2018
BUY
$15.87 - $22.4 $1.98 Million - $2.79 Million
124,613 Added 12.23%
1,143,910 $20.3 Million
Q2 2018

Aug 08, 2018
BUY
$18.56 - $22.45 $885,868 - $1.07 Million
47,730 Added 4.91%
1,019,297 $21.9 Million
Q1 2018

May 07, 2018
SELL
$22.15 - $31.89 $1.14 Million - $1.64 Million
-51,361 Reduced 5.02%
971,567 $21.5 Million
Q4 2017

Jan 17, 2018
BUY
$24.23 - $30.93 $59,339 - $75,747
2,449 Added 0.24%
1,022,928 $31.1 Million
Q3 2017

Nov 13, 2017
BUY
$23.35 - $29.24 $23.8 Million - $29.8 Million
1,020,479
1,020,479 $24.7 Million

Others Institutions Holding EXEL

# of Institutions
687
Shares Held
259M
Call Options Held
1.41M
Put Options Held
1.55M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email